4DMedical

4DMedical Gross Margin

The Gross Margin of 4DMedical (4DX.AX) as of Nov 3, 2026 is -539.23 %. In the previous year, Gross Margin was 92.07 % — a change of -685.70% (lower).

Gross Margin

-539.23 %

YoY

-685.70%

Last updated:

Gross Margin of 4DMedical is 2026 -539.23 % . Gross Margin of 4DMedical was 2025 92.07 % . It decreases by -685.70% lower compared to the previous year.

For 4DMedical, the gross margin of -539.2% is down versus 26.6% a few years ago.

The 4DMedical Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2019
-536.25 AUD
Jan 1, 2020
-659.96 AUD
Jan 1, 2021
57.67 AUD
Jan 1, 2022
26.62 AUD
Jan 1, 2023
95.25 AUD
Jan 1, 2024
93.69 AUD
Jan 1, 2025
92.07 AUD
Jan 1, 2026
-539.23 AUD
The 4DMedical Gross Margin history
YEARGross MarginYoY
-539.23 %-685.70%
92.07 %-1.74%
93.69 %-1.63%
95.25 %+257.85%
26.62 %-53.84%
57.67 %-108.74%
-659.96 %+23.07%
-536.25 %+40.39%
-381.97 %-99.75%
-152,283.95 %-165,906.88%
91.84 %-7.57%
99.36 %0.00%
99.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

4DMedical Stock analysis

What does 4DMedical do? 4DMedical Ltd. commercializes its XV Technology, a four-dimensional lung imaging platform, through FDA-cleared XV Lung Ventilation Analysis Software (XV LVA) and CT LVAS, delivered via a software-as-a-service model. The company sells these products to hospitals and clinics, including I-MED Radiology Network, which operates approximately 250 clinics nationwide. XV LVAS and CT LVAS reports are generated using the company’s software, leveraging existing hospital imaging equipment or the XV Scanner. The firm’s revenue comes from SaaS subscriptions and software licensing for its imaging solutions. I-MED Radiology Network is a key client, with 4DMedical initiating the commercial rollout of XV LVAS within its network. The company provides lung imaging technology to selected clinics across I-MED, utilizing the XV Scanner or existing hospital equipment. Revenue streams are derived from the SaaS delivery model, with no mention of additional products or services beyond XV LVA and CT LVAS. 4DMedical’s flagship technology powers dynamic lung ventilation analysis, enabling physicians to identify respiratory issues earlier. The company’s products are designed for use with existing hospital imaging systems, reducing the need for additional hardware. The primary buyers are medical imaging providers like I-MED, which integrate XV Technology into their diagnostic services for respiratory conditions. 4DMedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 4DMedical stock

Gross Margin of 4DMedical is -539.23 % in 2026.

Gross Margin of 4DMedical changed from 92.07 % to -539.23 %, representing a -685.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin 4DMedical since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's 4DMedical with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — 4DMedical

All Key Metrics — 4DMedical